Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aldeyra Therapeu (NQ: ALDX )

3.250 USD -0.220 (-6.34%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 915,192
Open 3.420
Bid (Size) 3.220 (1)
Ask (Size) 3.330 (2)
Prev. Close 3.470
Today's Range 3.240 - 3.520
52wk Range 3.240 - 15.95
Shares Outstanding 58,092,105
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aldeyra Therapeutics Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxalap, an Investigational New Drug, Compared to Xiidra®
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced positive... 
From Business Wire News Releases
Aldeyra Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BioConnect Virtual Conference
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced that Todd C.... 
From Business Wire News Releases

Performance

YTD
-23.89%
-23.89%
1 Month
-15.36%
-15.36%
3 Month
-59.53%
-59.53%
6 Month
-64.17%
-64.17%
1 Year
-72.43%
-72.43%

More News

Read More
Aldeyra Therapeutics Completes Enrollment in Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy
From Business Wire News Releases
Mid-Afternoon Market Update: Dow Jumps Over 500 Points; Rite Aid Shares Spike Higher
Tags Commodities PPSI ARDS
From Benzinga
Aldeyra Therapeutics Announces Top-Line Results from the Phase 3 TRANQUILITY Trial in Dry Eye Disease
From Business Wire News Releases
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tags Top Gainers Markets DBVT
From Benzinga
Mid-Day Market Update: Crude Oil Rises 3%; Aldeyra Therapeutics Shares Slide
Tags TGA News Intraday Update
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tags Markets Top Gainers DBVT
From Benzinga
10 Biggest Price Target Changes For Tuesday
Tags KLAC CIR LEN
From Benzinga
Stocks Set to Snap Selloff, Dow Eyes Triple-Digit Pop
Tags Market News Stocks / Equities
From TalkMarkets
Aldeyra's Dry Eye Disease Candidate Disappoints In Late-Stage Study
Tags Biotech Trading Ideas dry eye disease
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.